Citations (333)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Kyungsil Yoon, Seung Jun Kwack, Hyung Sik Kim & Byung-Mu Lee. (2014) Estrogenic Endocrine-Disrupting Chemicals: Molecular Mechanisms of Actions on Putative Human Diseases. Journal of Toxicology and Environmental Health, Part B 17:3, pages 127-174.
Read now
Read now
Saranya Chumsri, Amanda Schech, Chakkapong Chakkabat, Gauri Sabnis & Angela Brodie. (2014) Advances in mechanisms of resistance to aromatase inhibitors. Expert Review of Anticancer Therapy 14:4, pages 381-393.
Read now
Read now
Alessandro Peri, Susanna Benvenuti, Paola Luciani & Cristiana Deledda. (2012) Hormonal modulation of cholesterol: experimental evidence and possible translational impact. Expert Review of Endocrinology & Metabolism 7:3, pages 309-318.
Read now
Read now
Zeynep Madak-Erdogan, Mathieu Lupien, Fabio Stossi, Myles Brown & Benita S. Katzenellenbogen. (2011) Genomic Collaboration of Estrogen Receptor α and Extracellular Signal-Regulated Kinase 2 in Regulating Gene and Proliferation Programs. Molecular and Cellular Biology 31:1, pages 226-236.
Read now
Read now
Hatem A Azim Jr & Martine J Piccart. (2010) Simultaneous targeting of estrogen receptor and HER2 in breast cancer. Expert Review of Anticancer Therapy 10:8, pages 1255-1263.
Read now
Read now
Melanie Spears & John Bartlett. (2009) The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opinion on Therapeutic Targets 13:6, pages 665-674.
Read now
Read now
Raj Kumar & William J Calhoun. (2008) Differential regulation of the transcriptional activity of the glucocorticoid receptor through site-specific phosphorylation. Biologics: Targets and Therapy 2:4, pages 845-854.
Read now
Read now
Giuseppe Tonini, Gaia Schiavon, Maria Elisabetta Fratto, Bruno Vincenzi & Daniele Santini. (2008) Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions. Expert Opinion on Biological Therapy 8:2, pages 221-234.
Read now
Read now
Nan Zhu & Ulla Hansen. (2007) HMGN1 Modulates Estrogen-Mediated Transcriptional Activation through Interactions with Specific DNA-Binding Transcription Factors. Molecular and Cellular Biology 27:24, pages 8859-8873.
Read now
Read now
Larbi Amazit, Luigi Pasini, Adam T. Szafran, Valeria Berno, Ray-Chang Wu, Marylin Mielke, Elizabeth D. Jones, Maureen G. Mancini, Cruz A. Hinojos, Bert W. O'Malley & Michael A. Mancini. (2007) Regulation of SRC-3 Intercompartmental Dynamics by Estrogen Receptor and Phosphorylation. Molecular and Cellular Biology 27:19, pages 6913-6932.
Read now
Read now
Chao Li, Ray-Chang Wu, Larbi Amazit, Sophia Y. Tsai, Ming-Jer Tsai & Bert W. O'Malley. (2007) Specific Amino Acid Residues in the Basic Helix-Loop-Helix Domain of SRC-3 Are Essential for Its Nuclear Localization and Proteasome-Dependent Turnover. Molecular and Cellular Biology 27:4, pages 1296-1308.
Read now
Read now
Hina Naeem, Donghang Cheng, Qingshi Zhao, Caroline Underhill, Marc Tini, Marc T. Bedford & Joseph Torchia. (2007) The Activity and Stability of the Transcriptional Coactivator p/CIP/SRC-3 Are Regulated by CARM1-Dependent Methylation. Molecular and Cellular Biology 27:1, pages 120-134.
Read now
Read now
Anwar Hossain, Macus T. Kuo & Grady F. Saunders. (2006) Mir-17-5p Regulates Breast Cancer Cell Proliferation by Inhibiting Translation of AIB1 mRNA. Molecular and Cellular Biology 26:21, pages 8191-8201.
Read now
Read now
Maggie C. Louie, Alexey S. Revenko, June X. Zou, Jennifer Yao & Hong-Wu Chen. (2006) Direct Control of Cell Cycle Gene Expression by Proto-Oncogene Product ACTR, and Its Autoregulation Underlies Its Transforming Activity. Molecular and Cellular Biology 26:10, pages 3810-3823.
Read now
Read now
Pradeep K. Pandey, T. S. Udayakumar, Xinjie Lin, Dipali Sharma, Paul S. Shapiro & Joseph D. Fondell. (2005) Activation of TRAP/Mediator Subunit TRAP220/Med1 Is Regulated by Mitogen-Activated Protein Kinase-Dependent Phosphorylation. Molecular and Cellular Biology 25:24, pages 10695-10710.
Read now
Read now
Ping Yi, Ray-Chang Wu, Joshua Sandquist, Jiemin Wong, Sophia Y. Tsai, Ming-Jer Tsai, Anthony R. Means & Bert W. O'Malley. (2005) Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1). Molecular and Cellular Biology 25:21, pages 9687-9699.
Read now
Read now
Fuzhong F. Zheng, Ray-Chang Wu, Carolyn L. Smith & Bert W. O'Malley. (2005) Rapid Estrogen-Induced Phosphorylation of the SRC-3 Coactivator Occurs in an Extranuclear Complex Containing Estrogen Receptor. Molecular and Cellular Biology 25:18, pages 8273-8284.
Read now
Read now
Lisa K. Pierson-Mullany & Carol A. Lange. (2004) Phosphorylation of Progesterone Receptor Serine 400 Mediates Ligand-Independent Transcriptional Activity in Response to Activation of Cyclin-Dependent Protein Kinase 2. Molecular and Cellular Biology 24:24, pages 10542-10557.
Read now
Read now
Maggie C. Louie, June X. Zou, Alina Rabinovich & Hong-Wu Chen. (2004) ACTR/AIB1 Functions as an E2F1 Coactivator To Promote Breast Cancer Cell Proliferation and Antiestrogen Resistance. Molecular and Cellular Biology 24:12, pages 5157-5171.
Read now
Read now
Ge Zhou, Yoshihiro Hashimoto, Inseok Kwak, Sophia Y. Tsai & Ming-Jer Tsai. (2003) Role of the Steroid Receptor Coactivator SRC-3 in Cell Growth. Molecular and Cellular Biology 23:21, pages 7742-7755.
Read now
Read now
Mario Maira, Christine Martens, éric Batsché, Yves Gauthier & Jacques Drouin. (2003) Dimer-Specific Potentiation of NGFI-B (Nur77) Transcriptional Activity by the Protein Kinase A Pathway and AF-1-Dependent Coactivator Recruitment. Molecular and Cellular Biology 23:3, pages 763-776.
Read now
Read now
Leigh Murphy, Tracy Cherlet, Anthony Lewis, Yasmin Banu & Peter Watson. (2003) New insights into estrogen receptor function in human breast cancer. Annals of Medicine 35:8, pages 614-631.
Read now
Read now
Majdi S. Qutob, Rabindra N. Bhattacharjee, Elisa Pollari, Siu Pok Yee & Joseph Torchia. (2002) Microtubule-Dependent Subcellular Redistribution of the Transcriptional Coactivator p/CIP. Molecular and Cellular Biology 22:18, pages 6611-6626.
Read now
Read now
Ray-Chang Wu, Jun Qin, Yoshihiro Hashimoto, Jiemin Wong, Jianming Xu, Sophia Y. Tsai, Ming-Jer Tsai & Bert W. O'Malley. (2002) Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase. Molecular and Cellular Biology 22:10, pages 3549-3561.
Read now
Read now
Johan Lund, Bente Børud, Gunnar Mellgren, Reidun Æsøy, Tuyen Hoang, Anne L. Jacob & Marit Bakke. (2002) DIFFERENTIAL REGULATION OF SF-1-COFACTOR INTERACTIONS. Endocrine Research 28:4, pages 505-513.
Read now
Read now
Roberto Avola, Gianfrancesco Cormaci, Venera Mazzone, Luca Denaro, Fiorenzo Mignini, Daniele Tomassoni & Damiano Zaccheo. (2002) EFFECT OF GROWTH FACTORS ON DNA LABELING AND CYTOSKELETAL PROTEIN EXPRESSION IN 17-β-ESTRADIOL AND BASIC FIBROBLAST GROWTH FACTOR PRE-TREATED ASTROCYTE CULTURES. Clinical and Experimental Hypertension 24:7-8, pages 753-767.
Read now
Read now
Brian G. Rowan, Nefretiti Garrison, Nancy L. Weigel & Bert W. O'Malley. (2000) 8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein. Molecular and Cellular Biology 20:23, pages 8720-8730.
Read now
Read now
Articles from other publishers (306)
Léa Clusan, François Ferrière, Gilles Flouriot & Farzad Pakdel. (2023) A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences 24:7, pages 6834.
Crossref
Crossref
Young Joo Lee, Seung Pil Jung, Jeoung Won Bae, Sun Moon Yang, Ji Young You & Soo Youn Bae. (2023) Prognosis according to the timing of recurrence in breast cancer. Annals of Surgical Treatment and Research 104:1, pages 1.
Crossref
Crossref
Anthony W. Ashton, Harpreet K. Dhanjal, Benjamin Rossner, Huma Mahmood, Vivek I. Patel, Mohammad Nadim, Manpreet Lota, Farhan Shahid, Zhiping Li, David Joyce, Matyas Pajkos, Zsuzsanna Dosztányi, Xuanmao Jiao & Richard G. Pestell. (2022) Acetylation of nuclear receptors in health and disease: an update. The FEBS Journal.
Crossref
Crossref
Ruixue Zhou, Zhisheng Wang, Bojun Zhou, Zixin Yu, Chongyun Wu, Jun Hou, Ken Cheng & Timon Chengyi Liu. (2022) Estrogen receptors mediate the antidepressant effects of aerobic exercise: A possible new mechanism. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Muhammad Zafar Irshad Khan, Muhammad Uzair, Adila Nazli & Jian-Zhong Chen. (2022) An overview on Estrogen receptors signaling and its ligands in breast cancer. European Journal of Medicinal Chemistry 241, pages 114658.
Crossref
Crossref
David Musheyev & Anya Alayev. (2022) Endocrine therapy resistance: what we know and future directions. Exploration of Targeted Anti-tumor Therapy, pages 480-496.
Crossref
Crossref
Nguyen Xuan Thang, Seonho Yoo, Hyeonwoo La, Hyeonji Lee, Chanhyeok Park, Kyoung Sik Park & Kwonho Hong. (2022) Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer. Biomedicines 10:4, pages 748.
Crossref
Crossref
Ozge Saatci, Kim-Tuyen Huynh-Dam & Ozgur Sahin. (2021) Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategies. Journal of Molecular Medicine 99:12, pages 1691-1710.
Crossref
Crossref
Na Wang, Zhihong Gong, Jialin Wang, Wenteng Xu, Qian Yang & Songlin Chen. (2021) Characterization of Chinese tongue sole (Cynoglossus semilaevis) 24-dehydrocholesterol reductase: Expression profile, epigenetic modification, and its knock-down effect. General and Comparative Endocrinology 312, pages 113870.
Crossref
Crossref
Kristine Donahue & Wei Xu. 2021. Nuclear Receptors. Nuclear Receptors
379
410
.
Eirini Thanopoulou, Leila Khader, Morena Caira, Andrew Wardley, Johannes Ettl, Federica Miglietta, Patrick Neven & Valentina Guarneri. (2020) Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current Literature. Cancers 12:11, pages 3317.
Crossref
Crossref
Mengjia Hu, Yukai Lu, Yan Qi, Zihao Zhang, Song Wang, Yang Xu, Fang Chen, Yong Tang, Shilei Chen, Mo Chen, Changhong Du, Mingqiang Shen, Fengchao Wang, Yongping Su, Youcai Deng & Junping Wang. (2020) SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells. Cancer Immunology Research 8:9, pages 1150-1162.
Crossref
Crossref
Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker, Taylor K. Desautels, Robert Baldi, Christina A. Chao, Kendall A. Heetderks, Yeeun Bae, Rui Xiong, Debra A. Tonetti, Lauren M. Gutgesell, Jiong Zhao, Jessica A. Sorrentino, Delita A. Thompson, John E. Bisi, Jay C. Strum, Gregory R. J. Thatcher & John D. Norris. (2020) G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer. Breast Cancer Research and Treatment 180:3, pages 635-646.
Crossref
Crossref
N. Vasan, E. Toska & M. Scaltriti. (2019) Overview of the relevance of PI3K pathway in HR-positive breast cancer. Annals of Oncology 30, pages x3-x11.
Crossref
Crossref
Xiaoyong Fu, Carmine De Angelis, Jamunarani Veeraraghavan, C. Kent Osborne & Rachel Schiff. 2019. Estrogen Receptor and Breast Cancer. Estrogen Receptor and Breast Cancer
265
307
.
Snehangshu Kundu, Muhammad Akhtar Ali, Niklas Handin, Narendra Padhan, Jimmy Larsson, Maria Karoutsou, Kenneth Ban, Jacek R. Wiśniewski, Per Artursson, Liqun He, Mats Hellström & Tobias Sjöblom. (2018) Linking FOXO3, NCOA3, and TCF7L2 to Ras pathway phenotypes through a genome-wide forward genetic screen in human colorectal cancer cells. Genome Medicine 10:1.
Crossref
Crossref
Guoshun Pei, Yan Lan, Weijie Lu, Lina Ji & Zi‑Chun Hua. (2018) The function of FAK/CCDC80/E‑cadherin pathway in the regulation of B16F10 cell migration. Oncology Letters.
Crossref
Crossref
Viroj Boonyaratanakornkit, Nalo Hamilton, Diana C. Márquez-Garbán, Prangwan Pateetin, Eileen M. McGowan & Richard J. Pietras. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Molecular and Cellular Endocrinology 466, pages 51-72.
Crossref
Crossref
C Flaveny, M Kumar & G.H. Perdew. 2018. Comprehensive Toxicology. Comprehensive Toxicology
55
75
.
Sonja Thaler, Marcus Schmidt, Sven Roßwag, Gitta Thiede, Arno Schad & Jonathan P. Sleeman. (2017) Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells. Oncotarget 8:42, pages 72281-72301.
Crossref
Crossref
Doudou Huang, Fang Yang, Yucai Wang & Xiaoxiang Guan. (2017) Mechanisms of resistance to selective estrogen receptor down-regulator in metastatic breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:1, pages 148-156.
Crossref
Crossref
Jean-Francois ArnalFrançoise LenfantRaphaël MetivierGilles FlouriotDaniel HenrionMarine AdlanmeriniCoralie FontainePierre GourdyPierre ChambonBenita KatzenellenbogenJohn Katzenellenbogen. (2017) Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications. Physiological Reviews 97:3, pages 1045-1087.
Crossref
Crossref
Anna C. Groner & Myles Brown. (2017) Role of steroid receptor and coregulator mutations in hormone-dependent cancers. Journal of Clinical Investigation 127:4, pages 1126-1135.
Crossref
Crossref
Aabha Oza & Cynthia X. Ma. (2017) New Insights in Estrogen Receptor (ER) Biology and Implications for Treatment. Current Breast Cancer Reports 9:1, pages 13-25.
Crossref
Crossref
Jill M. Daniel & Kevin D. Beck. 2017. Learning and Memory: A Comprehensive Reference. Learning and Memory: A Comprehensive Reference
445
462
.
A.M. Etgen & L.M. Garcia-Segura. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior
23
53
.
Sepideh Mansouri, Azin Teymourzadeh, Leila Farahmand & Keivan Majidzadeh-A. 2017. Cancer Genetics and Psychotherapy. Cancer Genetics and Psychotherapy
825
850
.
Tianjiao Wang, Lin Mu, Haifeng Jin, Peng Zhang, Yueyue Wang, Xiaochi Ma, Jinjin Pan, Jian Miao & Yuhui Yuan. (2015) The effects of bufadienolides on HER2 overexpressing breast cancer cells. Tumor Biology 37:6, pages 7155-7163.
Crossref
Crossref
A. Peri. (2015) Neuroprotective effects of estrogens: the role of cholesterol. Journal of Endocrinological Investigation 39:1, pages 11-18.
Crossref
Crossref
Agostina Nardone, Carmine De Angelis, Meghana V. Trivedi, C. Kent Osborne & Rachel Schiff. (2015) The changing role of ER in endocrine resistance. The Breast 24, pages S60-S66.
Crossref
Crossref
XUEWEI PENG, FENGYU LI, PING WANG, SHENGNAN JIA, LILI SUN & HONGLIANG HUO. (2015) Apelin-13 induces MCF-7 cell proliferation and invasion via phosphorylation of ERK1/2. International Journal of Molecular Medicine 36:3, pages 733-738.
Crossref
Crossref
Victoria Shang Wu, Noriko Kanaya, Chiao Lo, Joanne Mortimer & Shiuan Chen. (2015) From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?. The Journal of Steroid Biochemistry and Molecular Biology 153, pages 45-53.
Crossref
Crossref
Vincenzo Bramanti, Sonia Grasso, Daniele Tibullo, Cesarina Giallongo, Giuseppina Raciti, Maria Viola & Roberto Avola. (2015) Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors. Journal of Neuroscience Research 93:9, pages 1378-1387.
Crossref
Crossref
Jill M. Daniel, Christine F. Witty & Shaefali P. Rodgers. (2015) Long-term consequences of estrogens administered in midlife on female cognitive aging. Hormones and Behavior 74, pages 77-85.
Crossref
Crossref
Cynthia X. Ma, Tomás Reinert, Izabela Chmielewska & Matthew J. Ellis. (2015) Mechanisms of aromatase inhibitor resistance. Nature Reviews Cancer 15:5, pages 261-275.
Crossref
Crossref
Angela Maselli, Marina Pierdominici, Cristiana Vitale & Elena Ortona. (2015) Membrane lipid rafts and estrogenic signalling: a functional role in the modulation of cell homeostasis. Apoptosis 20:5, pages 671-678.
Crossref
Crossref
Gayathri Nagaraj & Cynthia Ma. (2015) Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer. Breast Cancer Research and Treatment 150:2, pages 231-242.
Crossref
Crossref
ASTRID M. PEDERSEN, SUSAN THRANE, ANNE E. LYKKESFELDT & CHRISTINA W. YDE. (2014) Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α. International Journal of Oncology 45:5, pages 2167-2175.
Crossref
Crossref
Ifeyinwa E. Obiorah, Ping Fan, Surojeet Sengupta & V. Craig Jordan. (2014) Selective estrogen-induced apoptosis in breast cancer. Steroids 90, pages 60-70.
Crossref
Crossref
Ifeyinwa Obiorah, Surojeet Sengupta, Ramona Curpan & V. Craig Jordan. (2014) Defining the Conformation of the Estrogen Receptor Complex That Controls Estrogen-Induced Apoptosis in Breast Cancer. Molecular Pharmacology 85:5, pages 789-799.
Crossref
Crossref
Gladys Morrison, Xiaoyong Fu, Martin Shea, Sarmistha Nanda, Mario Giuliano, Tao Wang, Teresa Klinowska, C. Kent Osborne, Mothaffar F. Rimawi & Rachel Schiff. (2014) Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. Breast Cancer Research and Treatment 144:2, pages 263-272.
Crossref
Crossref
Victoria L WebberJ Michael Dixon. (2014)
Role of endocrine therapy in ER
+
/HER2
+
breast cancers
. Breast Cancer Management 3:1, pages 103-111.
Crossref
Crossref
F. Montemurro, S. Di Cosimo & G. Arpino. (2013) Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications. Annals of Oncology 24:11, pages 2715-2724.
Crossref
Crossref
Xiaoyong Fu, C. Kent Osborne & Rachel Schiff. (2013) Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer. The Breast 22, pages S12-S18.
Crossref
Crossref
Miao Wang, Feng Zhao, Shujing Li, Alan K. Chang, Zhaojun Jia, Yixuan Chen, Feihong Xu, Hongming Pan & Huijian Wu. (2013) AIB1 Cooperates with ERα to Promote Epithelial Mesenchymal Transition in Breast Cancer through SNAI1 Activation. PLoS ONE 8:6, pages e65556.
Crossref
Crossref
José Carretero, Enrique J. Blanco, Manuel Carretero, Marta Carretero-Hernández, Mª José García-Barrado, Mª Carmen Iglesias-Osma, Deborah Jane Burks & Jaime Font de Mora. (2013) The expression of AIB1 correlates with cellular proliferation in human prolactinomas. Annals of Anatomy - Anatomischer Anzeiger 195:3, pages 253-259.
Crossref
Crossref
Christine F. WittyLayne P. GardellaMaria C. PerezJill M. Daniel. (2013) Short-Term Estradiol Administration in Aging Ovariectomized Rats Provides Lasting Benefits for Memory and the Hippocampus: A Role for Insulin-Like Growth Factor-I. Endocrinology 154:2, pages 842-852.
Crossref
Crossref
I. Vaz-Luis, E.P. Winer & N.U. Lin. (2013) Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?. Annals of Oncology 24:2, pages 283-291.
Crossref
Crossref
SOOK SHIN, SANGPHIL OH, SEAYOON AN & RALF JANKNECHT. (2012) ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells. Oncology Reports 29:1, pages 306-314.
Crossref
Crossref
Zeynep Madak‐Erdogan, Tze‐Howe Charn, Yan Jiang, Edison T Liu, John A Katzenellenbogen & Benita S Katzenellenbogen. (2013) Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators. Molecular Systems Biology 9:1.
Crossref
Crossref
Irina U. Agoulnik & Nancy L. Weigel. 2013. Androgen-Responsive Genes in Prostate Cancer. Androgen-Responsive Genes in Prostate Cancer
1
11
.
Rocío García-Becerra, Nancy Santos, Lorenza Díaz & Javier Camacho. (2012) Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance. International Journal of Molecular Sciences 14:1, pages 108-145.
Crossref
Crossref
Line L Haugan Moi, Marianne Hauglid Flågeng, Jennifer Gjerde, Andre Madsen, Therese Halvorsen Røst, Oddrun Anita Gudbrandsen, Ernst A Lien & Gunnar Mellgren. (2012) Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. BMC Cancer 12:1.
Crossref
Crossref
Jiajun Cui, Katherine Germer, Tianying Wu, Jiang Wang, Jia Luo, Shao-chun Wang, Qianben Wang & Xiaoting Zhang. (2012) Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells. Cancer Research 72:21, pages 5625-5634.
Crossref
Crossref
Zhaoting Wu, Meng Yang, Hongjie Liu, Hongchao Guo, Yuan Wang, Hong Cheng & Lingyi Chen. (2012) Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance. Journal of Biological Chemistry 287:45, pages 38295-38304.
Crossref
Crossref
P. Luciani, C. Deledda, S. Benvenuti, I. Cellai, G. Modi, B. Fibbi, G. Danza, G. B. Vannelli & A. Peri. (2012) Relationship Between the Neuroprotective Effects of Insulin-Like Growth Factor-1 and 17β-Oestradiol in Human Neuroblasts. Journal of Neuroendocrinology 24:10, pages 1304-1310.
Crossref
Crossref
Cynthie Wong & Shiuan Chen. (2012) The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance. The Journal of Steroid Biochemistry and Molecular Biology 131:3-5, pages 83-92.
Crossref
Crossref
George C Bobustuc, Joshua S Smith, Sreeram Maddipatla, Sheila Jeudy, Arati Limaye, Beth Isley, Maria-Lourdes M Caparas, Susan M Constantino, Nikita Shah, Cheryl H Baker, Kalkunte S Srivenugopal, Said Baidas & Santhi D Konduri. (2012) MGMT Inhibition Restores ERα Functional Sensitivity to Antiestrogen Therapy. Molecular Medicine 18:6, pages 913-929.
Crossref
Crossref
Rosa Nadal, Ana Fernandez, Pedro Sanchez-Rovira, Marta Salido, María Rodríguez, José Luis García-Puche, Marta Macià, Josep Maria Corominas, Miguel Delgado-Rodriguez, Lucas Gonzalez, Joan Albanell, Mónica Fernández, Francesc Solé, José Antonio Lorente & María José Serrano. (2012) Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Research 14:3.
Crossref
Crossref
María F. Rubio, Pablo N. Larrosa Fernandez, Cecilia V. Alvarado, L.C. Panelo, Marina Ruiz Grecco, Georgina P. Colo, Giselle A. Martínez-Noel, Sabrina M. Micenmacher & Mónica A. Costas. (2012) Cyclin D1 is a NF-κB corepressor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:6, pages 1119-1131.
Crossref
Crossref
Ryan P Roop & Cynthia X Ma. (2012) Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies. Future Oncology 8:3, pages 273-292.
Crossref
Crossref
Macarena Ferrero & Jaime Font Mora. 2012. Cell Signaling & Molecular Targets in Cancer. Cell Signaling & Molecular Targets in Cancer
129
166
.
Ruchi Saxena & Anila Dwivedi. (2012) ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective. Medicinal Research Reviews 32:1, pages 166-215.
Crossref
Crossref
Macarena Ferrero, Juan Ferragud, Leonardo Orlando, Luz Valero, Manuel Sánchez del Pino, Rosa Farràs & Jaime Font de Mora. (2011) Phosphorylation of AIB1 at Mitosis Is Regulated by CDK1/CYCLIN B. PLoS ONE 6:12, pages e28602.
Crossref
Crossref
Ying Wang, David M. Lonard, Yang Yu, Dar-Chone Chow, Timothy G. Palzkill & Bert W. O'Malley. (2011) Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1. Molecular Endocrinology 25:12, pages 2041-2053.
Crossref
Crossref
A. Peri, S. Benvenuti, P. Luciani, C. Deledda & I. Cellai. (2011) Membrane cholesterol as a mediator of the neuroprotective effects of estrogens. Neuroscience 191, pages 107-117.
Crossref
Crossref
Zhang-Zhi Hu, Benjamin L. Kagan, Eric A. Ariazi, Dean S. Rosenthal, Lihua Zhang, Jordan V. Li, Hongzhan Huang, Cathy Wu, V. Craig Jordan, Anna T. Riegel & Anton Wellstein. (2011) Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells. PLoS ONE 6:6, pages e20410.
Crossref
Crossref
Saranya Chumsri, Timothy Howes, Ting Bao, Gauri Sabnis & Angela Brodie. (2011) Aromatase, aromatase inhibitors, and breast cancer. The Journal of Steroid Biochemistry and Molecular Biology 125:1-2, pages 13-22.
Crossref
Crossref
Anna Malovannaya, Rainer B. Lanz, Sung Yun Jung, Yaroslava Bulynko, Nguyen T. Le, Doug W. Chan, Chen Ding, Yi Shi, Nur Yucer, Giedre Krenciute, Beom-Jun Kim, Chunshu Li, Rui Chen, Wei Li, Yi Wang, Bert W. O'Malley & Jun Qin. (2011) Analysis of the Human Endogenous Coregulator Complexome. Cell 145:5, pages 787-799.
Crossref
Crossref
Xue DAI & Jie WU. (2011) Selective Estrogen Receptor Modulator: Raloxifene. Journal of Reproduction and Contraception 22:1, pages 51-60.
Crossref
Crossref
María‐Angeles Arévalo, Luis M. Garcia‐Segura & Iñigo Azcoitia. 2011. Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis. Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis
1
11
.
Mathieu Lupien, Clifford A. Meyer, Shannon T. Bailey, Jérôme Eeckhoute, Jennifer Cook, Thomas Westerling, Xiaoyang Zhang, Jason S. Carroll, Daniel R. Rhodes, X. Shirley Liu & Myles Brown. (2010) Growth factor stimulation induces a distinct ERα cistrome underlying breast cancer endocrine resistance. Genes & Development 24:19, pages 2219-2227.
Crossref
Crossref
Olga Varea, Maria-Angeles Arevalo, Juan Jose Garrido, Luis M. Garcia-Segura, Francisco Wandosell & Pablo Mendez. (2010) Interaction of estrogen receptors with insulin-like growth factor-I and Wnt signaling in the nervous system. Steroids 75:8-9, pages 565-569.
Crossref
Crossref
Rainer B. Lanz, Yaroslava Bulynko, Anna Malovannaya, Paul Labhart, Liguo Wang, Wei Li, Jun Qin, Mary Harper & Bert W. O'Malley. (2010) Global Characterization of Transcriptional Impact of the SRC-3 Coregulator. Molecular Endocrinology 24:4, pages 859-872.
Crossref
Crossref
Jumpei Asano, Toshihiro Kudo, Takeshi Shimizu, Yang Fan, Naoki Nanashima, Daisuke Yamana, Takuya Miura, Toshiyuki Yamada & Shigeki Tsuchida. (2010) Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis. Cancer Science 101:4, pages 869-875.
Crossref
Crossref
Pilar Eroles, Ana Bosch, Begoña Bermejo & Ana Lluch. (2010) Mechanisms of resistance to hormonal treatment in breast cancer. Clinical and Translational Oncology 12:4, pages 246-252.
Crossref
Crossref
Alexandra F. Leary, Suzanne Drury, Simone Detre, Sunil Pancholi, Anne E. Lykkesfeldt, Lesley-Ann Martin, Mitch Dowsett & Stephen R.D. Johnston. (2010) Lapatinib Restores Hormone Sensitivity with Differential Effects on Estrogen Receptor Signaling in Cell Models of Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer with Acquired Endocrine Resistance. Clinical Cancer Research 16:5, pages 1486-1497.
Crossref
Crossref
April Davoli, Barbara A. Hocevar & Thomas L. Brown. (2009) Progression and treatment of HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology 65:4, pages 611-623.
Crossref
Crossref
K. Leigh Greathouse & Cheryl L. Walker. 2010. Environmental Impacts on Reproductive Health and Fertility. Environmental Impacts on Reproductive Health and Fertility.
Pankaj TanejaDejan MaglicFumitake KaiSinan ZhuRobert D. KendigA. Fry ElizabethKazushi Inoue. (2010) Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance. Clinical Medicine Insights: Oncology 4, pages CMO.S4773.
Crossref
Crossref
Luis M. Garcia-Segura, María-Angeles Arévalo & Iñigo Azcoitia. 2010. Neuroendocrinology: The Normal Neuroendocrine System. Neuroendocrinology: The Normal Neuroendocrine System
251
272
.
C. Flaveny, M. Kumar & G.H. Perdew. 2010. Comprehensive Toxicology. Comprehensive Toxicology
183
206
.
Elin Swedenborg, Krista A. Power, Wen Cai, Ingemar Pongratz & Joëlle Rüegg. (2009) Regulation of estrogen receptor beta activity and implications in health and disease. Cellular and Molecular Life Sciences 66:24, pages 3873-3894.
Crossref
Crossref
Yang Zhang, Hua Su, Massod Rahimi, Ryan Tochihara & Careen Tang. (2009) EGFRvIII‐induced estrogen‐independence, tamoxifen‐resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer. International Journal of Cancer 125:9, pages 2021-2028.
Crossref
Crossref
Jianming Xu, Ray-Chang Wu & Bert W. O'Malley. (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nature Reviews Cancer 9:9, pages 615-630.
Crossref
Crossref
Anke van Rijk, Marcel Sweers, Erik Huys, Monique Kersten, Gerard Merkx, Ad Geurts van Kessel, Maria Debiec-Rychter & Eric F.P.M. Schoenmakers. (2009) Characterization of a recurrent t(1;2)(p36;p24) in human uterine leiomyoma. Cancer Genetics and Cytogenetics 193:1, pages 54-62.
Crossref
Crossref
Marc P. J. McCafferty, Roisin E. McNeill, Nicola Miller & Michael J. Kerin. (2009) Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer. Breast Cancer Research and Treatment 116:3, pages 425-432.
Crossref
Crossref
Alessandro Peri, Giovanna Danza, Susanna Benvenuti, Paola Luciani, Cristiana Deledda, Fabiana Rosati, Ilaria Cellai & Mario Serio. (2009) New insights on the neuroprotective role of sterols and sex steroids: The seladin-1/DHCR24 paradigm. Frontiers in Neuroendocrinology 30:2, pages 119-129.
Crossref
Crossref
Tyler Lahusen, Ralf T. Henke, Benjamin L. Kagan, Anton Wellstein & Anna T. Riegel. (2009) The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Research and Treatment 116:2, pages 225-237.
Crossref
Crossref
Susan J. Cleator, Eliyaz Ahamed, R. Charles Coombes & Carlo Palmieri. (2009) A 2009 Update on the Treatment of Patients with Hormone Receptor—Positive Breast Cancer. Clinical Breast Cancer 9, pages S6-S17.
Crossref
Crossref
Zhi Chai, Lihong Yang, Baofeng Yu, Quanren He, Wan-I Li, Ran Zhou, Ting Zhang, Xiaoying Zheng & Jun Xie. (2009) p38 Mitogen-activated protein kinase-dependent regulation of SRC-3 and involvement in retinoic acid receptor α signaling in embryonic cortical neurons. IUBMB Life 61:6, pages 670-678.
Crossref
Crossref
Todd W. Miller, Marianela Pérez-Torres, Archana Narasanna, Marta Guix, Olle Stål, Gizeh Pérez-Tenorio, Ana M. Gonzalez-Angulo, Bryan T. Hennessy, Gordon B. Mills, J. Phillip Kennedy, Craig W. Lindsley & Carlos L. Arteaga. (2009)
Loss of
Phosphatase and Tensin Homologue Deleted on Chromosome 10
Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer
. Cancer Research 69:10, pages 4192-4201.
Crossref
Crossref
Malini Harigopal, Jonas Heymann, Sriparna Ghosh, Valsamo Anagnostou, Robert L. Camp & David L. Rimm. (2008) Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome. Breast Cancer Research and Treatment 115:1, pages 77-85.
Crossref
Crossref
Akihide Ryo, Gerburg Wulf, Tae Ho Lee & Kun Ping Lu. (2009) Pinning down HER2–ER crosstalk in SMRT regulation. Trends in Biochemical Sciences 34:4, pages 162-165.
Crossref
Crossref
Aisling M. Redmond, Fiona T. Bane, Anthony T. Stafford, Marie McIlroy, Mary F. Dillon, Thomas B. Crotty, Arnold D. Hill & Leonie S. Young. (2009) Coassociation of Estrogen Receptor and p160 Proteins Predicts Resistance to Endocrine Treatment; SRC-1 is an Independent Predictor of Breast Cancer Recurrence. Clinical Cancer Research 15:6, pages 2098-2106.
Crossref
Crossref
Raquel Marin, Mario Díaz, Rafael Alonso, Amaya Sanz, María Angeles Arévalo & Luis M. Garcia-Segura. (2009) Role of estrogen receptor α in membrane-initiated signaling in neural cells: Interaction with IGF-1 receptor. The Journal of Steroid Biochemistry and Molecular Biology 114:1-2, pages 2-7.
Crossref
Crossref
Diana C. Márquez-Garbán, Hsiao-Wang Chen, Lee Goodglick, Michael C. Fishbein & Richard J. Pietras. (2009) Targeting Aromatase and Estrogen Signaling in Human Non-Small Cell Lung Cancer. Annals of the New York Academy of Sciences 1155:1, pages 194-205.
Crossref
Crossref
J Wen, R Li, Y Lu & M A Shupnik. (2008) Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions. Oncogene 28:4, pages 575-586.
Crossref
Crossref
J M P Pabona, M C Velarde, Z Zeng, F A Simmen & R C M Simmen. (2009) Nuclear receptor co-regulator Krüppel-like factor 9 and prohibitin 2 expression in estrogen-induced epithelial cell proliferation in the mouse uterus. Journal of Endocrinology 200:1, pages 63-73.
Crossref
Crossref
Marinella Zilli, Antonino Grassadonia, Nicola Tinari, Alessia Di Giacobbe, Simona Gildetti, Jamara Giampietro, Clara Natoli & Stefano Iacobelli. (2009) Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1795:1, pages 62-81.
Crossref
Crossref
S.K. Mani & B.W. O’Malley. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1467
1504
.
M.J. Tetel & C.A. Lange. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1439
1466
.
A.M. Etgen & L.M. Garcia-Segura. 2009. Hormones, Brain and Behavior. Hormones, Brain and Behavior
1121
1163
.
Robert I. Nicholson, Iain R. Hutcheson, Stephen Hiscox, Kathy M. Taylor & Julia M.W. Gee. 2009. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer. Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer
1
26
.
Ellis R. Levin. 2009. Hormone Receptors in Breast Cancer. Hormone Receptors in Breast Cancer
1
10
.
M A Thorat, D Turbin, A Morimiya, S Leung, Q Zhang, M-H Jeng, D G Huntsman, H Nakshatri & S Badve. (2008) Amplified in breast cancer 1 expression in breast cancer. Histopathology 53:6, pages 634-641.
Crossref
Crossref
Irina U. Agoulnik, William E. BingmanIIIIII, Manjula Nakka, Wei Li, Qianben Wang, X. Shirley Liu, Myles Brown & Nancy L. Nancy L.. (2008) Target Gene-Specific Regulation of Androgen Receptor Activity by p42/p44 Mitogen-Activated Protein Kinase. Molecular Endocrinology 22:11, pages 2420-2432.
Crossref
Crossref
Adriana Soto-Guzman, Teresa Robledo, Mario Lopez-Perez & Eduardo Perez Salazar. (2008) Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Molecular and Cellular Endocrinology 294:1-2, pages 81-91.
Crossref
Crossref
Sook Shin, Denis G. Bosc, James N. Ingle, Thomas C. Spelsberg & Ralf Janknecht. (2008) Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. Journal of Cellular Biochemistry 105:3, pages 866-874.
Crossref
Crossref
Shin-ichi Hayashi & Yuri Yamaguchi. (2008) Estrogen signaling pathway and hormonal therapy. Breast Cancer 15:4, pages 256-261.
Crossref
Crossref
A H Talukder, D-Q Li, B Manavathi & R Kumar. (2008) Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-α transactivation. Oncogene 27:39, pages 5233-5242.
Crossref
Crossref
Aleix Prat & José Baselga. (2008) The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nature Clinical Practice Oncology 5:9, pages 531-542.
Crossref
Crossref
Chao Li, Yao-Yun Liang, Xin-Hua Feng, Sophia Y. Tsai, Ming-Jer Tsai & Bert W. O'Malley. (2008) Essential Phosphatases and a Phospho-Degron Are Critical for Regulation of SRC-3/AIB1 Coactivator Function and Turnover. Molecular Cell 31:6, pages 835-849.
Crossref
Crossref
Eric A. Ariazi & V. Craig Jordan. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets
127
199
.
Andrew R. Green, Claire Burney, Christopher J. Granger, E. Claire Paish, Somaia El-Sheikh, Emad A. Rakha, Desmond G. Powe, R. Douglas Macmillan, Ian O. Ellis & Eleni Stylianou. (2007) The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome. Breast Cancer Research and Treatment 110:3, pages 427-437.
Crossref
Crossref
Xinghua Long, Meiyun Fan, Robert M. Bigsby & Kenneth P. Nephew. (2008) Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms. Molecular Cancer Therapeutics 7:7, pages 2096-2108.
Crossref
Crossref
Macarena Ferrero, Álvaro Avivar, María Carmen García-Macías & Jaime Font de Mora. (2008) Phosphoinositide 3-kinase/AKT Signaling Can Promote AIB1 Stability Independently of GSK3 Phosphorylation. Cancer Research 68:13, pages 5450-5459.
Crossref
Crossref
Valeria Berno, Larbi Amazit, Cruz Hinojos, Jeannie Zhong, Maureen G. Mancini, Zelton Dave Sharp & Michael A. Mancini. (2008) Activation of Estrogen Receptor-α by E2 or EGF Induces Temporally Distinct Patterns of Large-Scale Chromatin Modification and mRNA Transcription. PLoS ONE 3:5, pages e2286.
Crossref
Crossref
Mark P. Fereshteh, Maddalena T. Tilli, Sung Eun Kim, Jianming Xu, Bert W. O'Malley, Anton Wellstein, Priscilla A. Furth & Anna T. Riegel. (2008)
The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for
Neu
(ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice
. Cancer Research 68:10, pages 3697-3706.
Crossref
Crossref
C.D. Foradori, M.J. Weiser & R.J. Handa. (2008) Non-genomic actions of androgens. Frontiers in Neuroendocrinology 29:2, pages 169-181.
Crossref
Crossref
Nandini Vasudevan & Donald W. Pfaff. (2008) Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Frontiers in Neuroendocrinology 29:2, pages 238-257.
Crossref
Crossref
Grazia Arpino, Lisa Wiechmann, C. Kent Osborne & Rachel Schiff. (2008) Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance. Endocrine Reviews 29:2, pages 217-233.
Crossref
Crossref
Shin-ichi Hayashi & Yuri Yamaguchi. (2008) Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy. The Journal of Steroid Biochemistry and Molecular Biology 109:3-5, pages 201-206.
Crossref
Crossref
Louis Wing-Cheong Chow, Adrian Yun-San Yip, Wings Tjing-Yung Loo & Masakazu Toi. (2008) Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. Cancer Letters 262:2, pages 232-238.
Crossref
Crossref
Philippe L. Bedard, Orit C. Freedman, Anthony Howell & Mark Clemons. (2007) Overcoming endocrine resistance in breast cancer—are signal transduction inhibitors the answer?. Breast Cancer Research and Treatment 108:3, pages 307-317.
Crossref
Crossref
Peter Dudek & Didier Picard. (2008) Genomics of Signaling Crosstalk of Estrogen Receptor α in Breast Cancer Cells. PLoS ONE 3:3, pages e1859.
Crossref
Crossref
Jeff L. Staudinger & Kristin Lichti. (2007) Cell Signaling and Nuclear Receptors: New Opportunities for Molecular Pharmaceuticals in Liver Disease. Molecular Pharmaceutics 5:1, pages 17-34.
Crossref
Crossref
Carol A. Lange. (2008) Integration of progesterone receptor action with rapid signaling events in breast cancer models. The Journal of Steroid Biochemistry and Molecular Biology 108:3-5, pages 203-212.
Crossref
Crossref
Seho ParkMin Kyu HeoMi Jeong LeeJoo-hee KimByeong-Woo Park. (2008) Changes of Coregulators, MAP Kinase Activity and p27/kip1 with Estrogen or Antiestrogen Treatment in Breast Cancer Cell Line. Journal of Breast Cancer 11:2, pages 56.
Crossref
Crossref
Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Filitsa A. Badra & Athanasios G. Papavassiliou. (2007) SUMO and estrogen receptors in breast cancer. Breast Cancer Research and Treatment 107:2, pages 195-210.
Crossref
Crossref
Daniel Gioeli, Sarah Kraus & Michael J. Weber. 2008. Prostate Cancer. Prostate Cancer
223
256
.
Carol A. Lange, Carol A. Sartorius, Hany Abdel-Hafiz, Monique A. Spillman, Kathryn B. Horwitz & Britta M. Jacobsen. 2008. Innovative Endocrinology of Cancer. Innovative Endocrinology of Cancer
94
111
.
A. Urruticoechea. (2008) The oestrogen-dependent biology of breast cancer. Sensitivity and resistance to aromatase inhibitors revisited: a molecular perspective. Clinical and Translational Oncology 9:12, pages 752-759.
Crossref
Crossref
Joseph Gligorov, David Azria, Moise Namer, David Khayat & Jean-Philippe Spano. (2007) Novel therapeutic strategies combining antihormonal and biological targeted therapies in breast cancer: Focus on clinical trials and perspectives. Critical Reviews in Oncology/Hematology 64:2, pages 115-128.
Crossref
Crossref
R. I. Nicholson, I. R. Hutcheson, H. E. Jones, S. E. Hiscox, M. Giles, K. M. Taylor & J. M. W. Gee. (2007) Growth factor signalling in endocrine and anti-growth factor resistant breast cancer. Reviews in Endocrine and Metabolic Disorders 8:3, pages 241-253.
Crossref
Crossref
Kelly A. Green & Jason S. Carroll. (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nature Reviews Cancer 7:9, pages 713-722.
Crossref
Crossref
Richard J. Pietras & Diana C. Márquez-Garbán. (2007) Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers. Clinical Cancer Research 13:16, pages 4672-4676.
Crossref
Crossref
Rajeshwar Rao Tekmal, Hareesh B. Nair, Rao P. Perla & Nameer Kirma. (2007) HER-2/neu×aromatase double transgenic mice model: The effects of aromatase overexpression on mammary tumorigenesis. The Journal of Steroid Biochemistry and Molecular Biology 106:1-5, pages 111-118.
Crossref
Crossref
Nina Heldring, Ashley Pike, Sandra Andersson, Jason Matthews, Guojun Cheng, Johan Hartman, Michel Tujague, Anders Ström, Eckardt Treuter, Margaret Warner & Jan-Åke Gustafsson. (2007) Estrogen Receptors: How Do They Signal and What Are Their Targets. Physiological Reviews 87:3, pages 905-931.
Crossref
Crossref
Alyssa E. Johnson, Isabelle P. Le, Abby Buchwalter & Maria A. Burnatowska-Hledin. (2006) Estrogen-dependent growth and estrogen receptor (ER)-α concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Molecular and Cellular Biochemistry 301:1-2, pages 13-20.
Crossref
Crossref
Shaosi Li & Yongfeng Shang. (2007) Regulation of SRC family coactivators by post-translational modifications. Cellular Signalling 19:6, pages 1101-1112.
Crossref
Crossref
Ray-Chang Wu, Qin Feng, David M. Lonard & Bert W. O'Malley. (2007) SRC-3 Coactivator Functional Lifetime Is Regulated by a Phospho-Dependent Ubiquitin Time Clock. Cell 129:6, pages 1125-1140.
Crossref
Crossref
Hideki Sakaguchi, Jiro Fujimoto, Wen-Shu Sun & Teruhiko Tamaya. (2007) Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. The Journal of Steroid Biochemistry and Molecular Biology 104:3-5, pages 237-240.
Crossref
Crossref
Suleiman Massarweh & Rachel Schiff. (2007) Unraveling the Mechanisms of Endocrine Resistance in Breast Cancer: New Therapeutic Opportunities. Clinical Cancer Research 13:7, pages 1950-1954.
Crossref
Crossref
Han-Jong Kim, Joon-Young Kim, Zhaojing Meng, Li Hua Wang, Fa Liu, Thomas P. Conrads, Terrence R. Burke, Timothy D. Veenstra & William L. Farrar. (2007) 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Transcriptional Activity of Estrogen Receptor-α via Covalent Modification of DNA-Binding Domain. Cancer Research 67:6, pages 2595-2602.
Crossref
Crossref
Tove Kirkegaard, Liane M. McGlynn, Fiona M. Campbell, Sven Müller, Sian M. Tovey, Barbara Dunne, Kirsten V. Nielsen, Timothy G. Cooke & John M.S. Bartlett. (2007) Amplified in Breast Cancer 1 in Human Epidermal Growth Factor Receptor–Positive Tumors of Tamoxifen-Treated Breast Cancer Patients. Clinical Cancer Research 13:5, pages 1405-1411.
Crossref
Crossref
Carol A. LangeDaniel GioeliStephen R. HammesPaul C. Marker. (2007) Integration of Rapid Signaling Events with Steroid Hormone Receptor Action in Breast and Prostate Cancer. Annual Review of Physiology 69:1, pages 171-199.
Crossref
Crossref
Renée Chmelar, Grant Buchanan, Eleanor F. Need, Wayne Tilley & Norman M. Greenberg. (2007) Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. International Journal of Cancer 120:4, pages 719-733.
Crossref
Crossref
Nandini Vasudevan & Donald W. Pfaff. (2007) Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles. Endocrine Reviews 28:1, pages 1-19.
Crossref
Crossref
Diana C. Márquez-Garbán, Hsiao-Wang Chen, Michael C. Fishbein, Lee Goodglick & Richard J. Pietras. (2007) Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72:2, pages 135-143.
Crossref
Crossref
P. Fumoleau, M. Campone, B. Coudert, F. Mayer, L. Favier & E. Ferrant. 2007. Cancer du sein. Cancer du sein
453
498
.
Laura Lambert & Khandan Keyomarsi. 2007. Breast Cancer Chemosensitivity. Breast Cancer Chemosensitivity
52
69
.
J. D. Blaustein & S. K. Mani. 2007. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology
95
149
.
Pierre Germain, Bart Staels, Catherine Dacquet, Michael Spedding & Vincent Laudet. (2006) Overview of Nomenclature of Nuclear Receptors. Pharmacological Reviews 58:4, pages 685-704.
Crossref
Crossref
Pablo Mendez, Francisco Wandosell & Luis M. Garcia-Segura. (2006) Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: Cellular and molecular mechanisms. Frontiers in Neuroendocrinology 27:4, pages 391-403.
Crossref
Crossref
Li Hua Wang, Xiao Yi Yang, Xiaohu Zhang, Ping An, Han-Jong Kim, Jiaqiang Huang, Robert Clarke, C. Kent Osborne, John K. Inman, Ettore Appella & William L. Farrar. (2006) Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. Cancer Cell 10:6, pages 487-499.
Crossref
Crossref
Tomoko Tanaka, Taijiro Okabe, Shigeki Gondo, Mitsue Fukuda, Masahiro Yamamoto, Tsukuru Umemura, Kenzaburo Tani, Masatoshi Nomura, Kiminobu Goto, Toshihiko Yanase & Hajime Nawata. (2006) Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell apoptosis. Experimental Hematology 34:11, pages 1542-1552.
Crossref
Crossref
Amalia Milano, Lissandra Dal Lago, Christos Sotiriou, Martine Piccart & Fatima Cardoso. (2006) What clinicians need to know about antioestrogen resistance in breast cancer therapy. European Journal of Cancer 42:16, pages 2692-2705.
Crossref
Crossref
Gregory E. Weitsman, Lin Li, George P. Skliris, James R. Davie, Kanyarat Ung, Yulian Niu, Linda Curtis-Snell, Ladislav Tomes, Peter H. Watson & Leigh C. Murphy. (2006) Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 Overexpression. Cancer Research 66:20, pages 10162-10170.
Crossref
Crossref
Ingo K. Mellinghoff. 2006. Prostate Cancer: Translational and Emerging Therapies. Prostate Cancer: Translational and Emerging Therapies
163
178
.
V. Craig Jordan. (2006) The Science of Selective Estrogen Receptor Modulators: Concept to Clinical Practice. Clinical Cancer Research 12:17, pages 5010-5013.
Crossref
Crossref
Aparna Mani, Annabell S. Oh, Emma T. Bowden, Tyler Lahusen, Kevin L. Lorick, Allan M. Weissman, Richard Schlegel, Anton Wellstein & Anna T. Riegel. (2006) E6AP Mediates Regulated Proteasomal Degradation of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 in Immortalized Cells. Cancer Research 66:17, pages 8680-8686.
Crossref
Crossref
Bich N. Duong, Steven Elliott, Daniel E. Frigo, Lilia I. Melnik, Lyndsay Vanhoy, Suzanne Tomchuck, Helena P. Lebeau, Odile David, Barbara S. Beckman, Jawed Alam, Melyssa R. Bratton, John A. McLachlan & Matthew E. Burow. (2006) AKT Regulation of Estrogen Receptor β Transcriptional Activity in Breast Cancer. Cancer Research 66:17, pages 8373-8381.
Crossref
Crossref
F. CARDOSO, L. DAL LAGO & S. BRAGA. (2006) Better predictive factors in endocrine-responsive breast cancer than the estrogen receptor itself. International Journal of Gynecological Cancer 16:s2, pages 533-537.
Crossref
Crossref
Huijian Wu, Luyang Sun, Ying Zhang, Yupeng Chen, Bin Shi, Ruifang Li, Yan Wang, Jing Liang, Dongwei Fan, Ge Wu, Dan Wang, Shaosi Li & Yongfeng Shang. (2006) Coordinated Regulation of AIB1 Transcriptional Activity by Sumoylation and Phosphorylation. Journal of Biological Chemistry 281:31, pages 21848-21856.
Crossref
Crossref
Pablo Mendez & Luis Miguel Garcia-Segura. (2006) Phosphatidylinositol 3-Kinase and Glycogen Synthase Kinase 3 Regulate Estrogen Receptor-Mediated Transcription in Neuronal Cells. Endocrinology 147:6, pages 3027-3039.
Crossref
Crossref
V. Craig Jordan. (2006) Pak up Your Breast Tumor—and Grow!. JNCI: Journal of the National Cancer Institute 98:10, pages 657-659.
Crossref
Crossref
Selina Glaros, Natasha Atanaskova, Changqing Zhao, Debra F. Skafar & Kaladhar B. Reddy. (2006) Activation Function-1 Domain of Estrogen Receptor Regulates the Agonistic and Antagonistic Actions of Tamoxifen. Molecular Endocrinology 20:5, pages 996-1008.
Crossref
Crossref
R. Longo, M.R. D'Andrea & G. Gasparini. (2018) Sequential Adjuvant Hormone Therapy in Postmenopausal Breast Cancer: Rationale and Clinical Results. The International Journal of Biological Markers 21:2, pages 111-122.
Crossref
Crossref
Jun YAN, Sophia Y TSAI & Ming-jer TSAI. (2006) SRC-3/AIB1: transcriptional coactivator in oncogenesis1. Acta Pharmacologica Sinica 27:4, pages 387-394.
Crossref
Crossref
M F Rubio, S Werbajh, E G A Cafferata, A Quaglino, G P Coló, I M Nojek, E C Kordon, V E Nahmod & M A Costas. (2005) TNF-α enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:9, pages 1367-1377.
Crossref
Crossref
Michelle M. Tabb & Bruce Blumberg. (2006) New Modes of Action for Endocrine-Disrupting Chemicals. Molecular Endocrinology 20:3, pages 475-482.
Crossref
Crossref
Susan Colilla, Philip W. Kantoff, Susan L. Neuhausen, Andrew K. Godwin, Mary B. Daly, Steven A. Narod, Judy E. Garber, Henry T. Lynch, Myles Brown, Barbara L. Weber & Timothy R. Rebbeck. (2006) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis 27:3, pages 599-605.
Crossref
Crossref
Displaying 200 of 333 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list